Ligand Pharmaceuticals
LGND
#3048
Rank
NZ$9.39 B
Marketcap
NZ$471.45
Share price
-1.61%
Change (1 day)
74.39%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2026 (TTM): NZ$0.32 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.27 Billion. In 2025 the company made an earning of NZ$0.27 Billion, an increase over its 2024 earnings that were of NZ$9.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.32 B18.78%
2025 NZ$0.27 B2848.57%
2024 NZ$9.34 M-91.37%
2023 NZ$0.10 B-7.59%
2022 NZ$0.11 B4%
2021 NZ$0.11 B296.42%
2020 NZ$28.43 M-97.97%
2019 NZ$1.40 B275.62%
2018 NZ$0.37 B237.48%
2017 NZ$0.11 B49.05%
2016 NZ$74.19 M55.41%
2015 NZ$47.73 M36.87%
2014 NZ$34.87 M29.59%
2013 NZ$26.91 M1309.35%
2012 NZ$1.9 M-43.97%
2011 NZ$3.4 M-113.19%
2010 -NZ$25.85 Million59.86%
2009 -NZ$16.17 Million-61.33%
2008 -NZ$41.81 Million-58.75%
2007 -NZ$0.11 Billion20.52%
2006 -NZ$84.09 Million81.27%
2005 -NZ$46.39 Million
2003 -NZ$32.3 Million-20.6%
2002 -NZ$40.68 Million4.38%
2001 -NZ$38.97 Million-48.83%
2000 -NZ$76.15 Million-19.74%
1999 -NZ$94.88 Million-19.06%
1998 -NZ$0.12 Billion126.71%
1997 -NZ$51.71 Million-5.83%
1996 -NZ$54.91 Million136.23%
1995 -NZ$23.25 Million-33.97%
1994 -NZ$35.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$43.75 B 13,538.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$17.83 B 5,460.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$52.41 B 16,240.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.30 B 4,670.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-NZ$0.86 Billion-366.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.14 B 6,804.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.16 B 4,938.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$16.86 B 5,155.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion-132.49%๐Ÿ‡บ๐Ÿ‡ธ USA